Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

Study ID: NCT06274034
Start Date: 2024-01-08
End Date: 2029-01-31
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

40

Intervention / Treatment

Electronic Health Record Review

Medical Device Usage and Evaluation

Meditation Therapy

Survey Administration

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Study ID: NCT04105270
Start Date: 2022-11-30
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

82

Intervention / Treatment

Oral Restorative Microbiota Therapy (RMT) Capsules

Durvalumab 1500 mg IV

Cisplatin/pemetrexed or Carboplatin/pemetrexed

Placebo

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

FAMILY Sleep Program

Study ID: NCT06571305
Start Date: 2024-08-01
End Date: 2026-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

Brief Behavioral Treatment for Insomnia (BBTI)

My Sleep Our Sleep (MSOS)

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

Study ID: NCT04743505
Start Date: 2022-01-18
End Date: 2030-05-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

APL-101

Osimertinib

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Study in Patients With Breast Cancer Leptomeningeal Metastasis

Study ID: NCT06638294
Start Date: 2024-11-25
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

Study ID: NCT06562777
Start Date: 2023-09-15
End Date: 2026-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Non-Interventional Study

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Study ID: NCT06312137
Start Date: 2024-04-03
End Date: 2034-10-23
Study Type

Interventional

Study Phase

Phase3

No. of Participants

780

Intervention / Treatment

Sacituzumab tirumotecan

Pembrolizumab

Cisplatin

Pemetrexed

Gemcitabine

Carboplatin

Paclitaxel

Rescue medication

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)

Study ID: NCT04606030
Start Date: 2020-10-26
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

BioBridge® Collagen Matrix

Vascularized Lymph Node Transfer (VLNT)

Sponsor

Fibralign Corporation

Source: clinicaltrials.gov

Share:
Add to list

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

Study ID: NCT05556928
Start Date: 2020-07-21
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5000

Intervention / Treatment
Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors

Study ID: NCT06028022
Start Date: 2023-10-18
End Date: 2026-10-16
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Mushroom Extract

Placebo Administration

Quality-of-Life Assessment

Administration Questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list